Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Sound waves could ease chronic leg swelling

NCT ID NCT07626645

First seen Jun 05, 2026

Summary

This study tests whether a device that delivers sound waves (shock wave therapy) can help reduce leg swelling and improve quality of life in people with lower limb lymphedema. Thirty-six adults who are already using standard care will either get real or fake (sham) treatments twice a week for five sessions. Researchers will measure changes in leg volume, skin thickness, pain, and function.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EXTRACORPOREAL SHOCK WAVE THERAPY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Gazi University Hospital, Department of Physical Medicine and Rehabilitation, Ankara, 06560

    Ankara, Yenimahalle, 06560, Turkey (Türkiye)

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Extracorporeal shock wave therapy (ESWT) using a device that delivers sound waves to the leg

What this could lead to

If it works, this could offer a new, non-invasive way to reduce leg swelling and improve comfort for people with lymphedema who still have symptoms despite standard care.

What could go wrong

This is a small, early-stage trial with only 36 people, so results may not apply to everyone. The treatment is added to standard care, so any benefit may be modest.

Conditions

The condition(s) this trial relates to.

lymphedema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.